Health Care & Life Sciences » Biotechnology | Beijing SL Pharmaceutical Co. Ltd.

Beijing SL Pharmaceutical Co. Ltd. A | Mutual Funds

Mutual Funds that own Beijing SL Pharmaceutical Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Nanfang CSI 500 ETF
1,743,915
0.31%
-102,900
0.43%
12/31/2017
1,151,951
0.2%
-767,335
1.27%
12/31/2017
910,174
0.16%
-686,536
3.9%
12/31/2017
678,457
0.12%
-92,300
6%
12/31/2017
600,050
0.11%
600,050
3.31%
12/31/2017
China SME ETF
570,860
0.1%
-89,600
1.03%
12/31/2017
394,876
0.07%
-258,600
0.95%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
345,900
0.06%
0
0%
07/31/2018
249,035
0.04%
-61,100
5.08%
12/31/2017
248,917
0.04%
22,900
0.94%
12/31/2017

About Beijing SL Pharmaceutical Co.

View Profile
Address
Building 1, Bitong Park
Beijing Beijing 100143
China
Employees -
Website http://www.slpharm.com.cn
Updated 07/08/2019
Beijing SL Pharmaceutical Co., Ltd. engages in the development of new drugs. Its products include anti-tumor tablets, liver tablets; cardiovascular and osteoporosis medication, recombinant products, small volume injection, freeze-dried powder, capsules, granules, and pharmaceutical raw materials. The company was founded in December 1994 and is headquartered in Beijing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.